tiprankstipranks
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market
GPCR
Structure Therapeutics, Inc. Sponsored ADR
RESEARCH TOOLSreports
Want to see GPCR full AI Analyst Report?

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Stock News & Sentiment

1,255 Followers
Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
Premium
Market News
Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
15d ago
LLY
PFE
Structure Therapeutics Appoints Matthew Lang as Chief Operating Officer
Premium
Company Announcements
Structure Therapeutics Appoints Matthew Lang as Chief Operating Officer
18d ago
8K
GPCR
Buy Rating on GPCR Driven by Competitive Aleniglipron Phase 2b Efficacy and Clear Path to Phase 3 in Obesity
Premium
Ratings
Buy Rating on GPCR Driven by Competitive Aleniglipron Phase 2b Efficacy and Clear Path to Phase 3 in Obesity
2M ago
GPCR
Buy Rating on Structure Therapeutics: Aleniglipron’s Strengthening Clinical Profile and Undervalued Global Obesity Opportunity
Premium
Ratings
Buy Rating on Structure Therapeutics: Aleniglipron’s Strengthening Clinical Profile and Undervalued Global Obesity Opportunity
2M ago
GPCR
Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results
Premium
Company Announcements
Structure Therapeutics Reports Strong Phase 2 Obesity Drug Results
2M ago
8K
GPCR
Leveraging External Amylin Validation: Positioning Structure Therapeutics’ Amylin and Oral GLP‑1 Platform for Combination-Driven Upside
Premium
Ratings
Leveraging External Amylin Validation: Positioning Structure Therapeutics’ Amylin and Oral GLP‑1 Platform for Combination-Driven Upside
2M ago
GPCR
Buy Rating on Structure Therapeutics: Strong Phase II Data and Upcoming Late‑Stage Catalysts Support Upside for Oral GLP‑1 Aleniglipron
Premium
Ratings
Buy Rating on Structure Therapeutics: Strong Phase II Data and Upcoming Late‑Stage Catalysts Support Upside for Oral GLP‑1 Aleniglipron
2M ago
GPCR
More GPCR News >

GPCR News on the Web

Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
TipRanks News
Neutral
Structure Therapeutics Appoints Matthew Lang as Chief Operating Officer
TipRanks News
Neutral
Structure Therapeutics appoints Matthew Lang as COO
TipRanks News
Neutral
Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?
Zacks
Neutral
Why Structure Therapeutics Stock Is Suddenly Sinking
TipRanks News
Bearish
Why Structure Therapeutics Shares Are Sliding Today
TipRanks News
Bearish
How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval
Zacks
Neutral
Why Structure Therapeutics Stock Suddenly Took Off Today
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
GPCR
Sector Average
Media Buzz
This Week4 articles
Weekly Average3.75 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GPCR’s Media Buzz Sentiment?
4 articles about GPCR were published this week. In an average week, 3.75 articles are published.
    What is GPCR’s weekly average amount of articles?
    In an average week, 3.75 articles about GPCR are published.
      What is GPCR’s News Sentiment?
      50% of articles about GPCR were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week